Streetbeat News

CING

Cingulate Inc.

https://www.cingulate.com

Industry

Biotechnology

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Open

4.19

Mkt cap

13M

Volume

25K

High

4.19

P/E Ratio

-0.09

52-wk high

152.40

Low

4.01

Div yield

N/A

52-wk low

1.80

During Monday's intraday session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a 91% increase, while RenovoRx (RNXT) and Jin Medical International (ZJYL) rose by 49.65% and 39.94%, respectively. Aditxt (ADTX), Celularity (CELU), and Ekso Bionics Holdings (EKSO) also saw substantial gains. Conversely, Cue Health (HLTH), SenesTech (SNES), Bone Biologics (BBLG), Processa Pharma (PCSA), Fortress Biotech (FBIO), and Cingulate (CING) experienced notable declines.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 5:30 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Gainers included China SXT Pharmaceuticals (SXTC) with a 185.1% increase, cbdMD (YCBD) up by 62.04%, and Kintara Therapeutics (KTRA) rising by 48.91%. Aditxt (ADTX), Jin Medical International (ZJYL), and Elicio Therapeutics (ELTX) also saw notable gains. Conversely, Microbot Medical (MBOT), Cingulate (CING), Scinai Immunotherapeutics (SCNI), SenesTech (SNES), Fortress Biotech (FBIO), and Enveric Biosciences (ENVB) were among the losers, with declines ranging from 16.03% to 24.4%.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 1:05 pm

Fisker Inc. (NYSE:FSR) shares surged over 20% after the company reported a 300% increase in deliveries from Q3 to Q4, with total deliveries around 4,700, primarily of the Fisker Ocean One launch edition. Other stocks also showed significant movement in Friday's mid-day session, with notable gainers and losers across various sectors.

Portfolio Pulse from Avi Kapoor

December 29, 2023 | 6:03 pm

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares increased by 15.2% in pre-market trading after announcing a 1-for-20 reverse stock split. Other stocks also showed significant movement in pre-market trading, with notable gainers including China Green Agriculture, Inc. (NYSE:CGA), FLJ Group Limited (NASDAQ:FLJ), and Kintara Therapeutics, Inc. (NASDAQ:KTRA). Conversely, several stocks experienced declines, such as flyExclusive Inc (NYSE:FLYX), Cingulate Inc. (NASDAQ:CING), and SenesTech, Inc. (NASDAQ:SNES).

Portfolio Pulse from Avi Kapoor

December 29, 2023 | 1:51 pm

In Friday's pre-market session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a substantial increase of 154.2%, while cbdMD (YCBD) rose by 48.12%. Other gainers included Kintara Therapeutics (KTRA), Lineage Cell Therapeutics (LCTX), Connect Biopharma Hldgs (CNTB), and China Pharma Holding (CPHI). Conversely, Microbot Medical (MBOT) led the losers with a 25.9% decline, followed by SenesTech (SNES), Cingulate (CING), Bone Biologics (BBLG), Universe Pharmaceuticals (UPC), and Ocean Biomedical (OCEA).

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 1:06 pm

The CNN Money Fear and Greed Index remains in the 'Extreme Greed' zone, indicating strong market sentiment. The S&P 500 is close to its record high, with a slight 0.3% decrease from its peak. The Fed is expected to cut rates by 25 basis points in March, with a 74.1% probability. Economic data shows a rise in jobless claims and an increased trade deficit, while pending home sales remained unchanged. Cingulate Inc. (CING) saw a 146% stock surge after receiving FDA guidance for its ADHD drug candidate. Most S&P 500 sectors ended positively, except for energy and materials. The Dow Jones and S&P 500 are expected to close the year with significant gains.

Portfolio Pulse from Avi Kapoor

December 29, 2023 | 10:50 am

In Thursday's after-market session, several healthcare stocks experienced significant movements. Gainers included cbdMD (YCBD), CEL-SCI (CVM), DermTech (DMTK), China Pharma Holding (CPHI), Accuray (ARAY), and Yield10 Bioscience (YTEN), with increases ranging from 5.08% to 16.5%. Losers comprised Cingulate (CING), Microbot Medical (MBOT), T2 Biosystems (TTOO), SenesTech (SNES), NKGen Biotech (NKGN), and AquaBounty Techs (AQB), with declines between 6.15% and 14.9%.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 9:31 pm

U.S. stocks closed higher with the Dow Jones gaining over 100 points. Utilities shares led gains, while energy shares lagged. Microbot Medical, Cingulate, and DouYu International saw significant share price movements after company-specific news. Conversely, Cytosorbents, Bluejay Diagnostics, and Velo3D experienced sharp declines. Crude oil inventories dropped significantly, exceeding market expectations. Economic data showed a rise in jobless claims and a widening trade deficit in goods, while wholesale inventories and pending home sales remained relatively stable.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 7:32 pm

DouYu International Holdings Limited (NASDAQ:DOYU) announced a share repurchase program of up to $20 million of ordinary shares in the form of ADSS, causing its shares to rise by 14.2% to $0.8320. Other stocks experienced significant movements in Thursday's mid-day session, with various companies seeing substantial gains and losses for diverse reasons, including FDA guidance, analyst ratings, public offerings, and patent lawsuit outcomes.

Portfolio Pulse from Avi Kapoor

December 28, 2023 | 6:07 pm

Health care stocks experienced significant movement in Thursday's intraday session. Cingulate, SenesTech, Jin Medical International, Microbot Medical, Ocean Biomedical, and Bone Biologics saw their shares rise by 125.8%, 107.53%, 58.53%, 36.71%, 30.51%, and 27.53% respectively. Conversely, CytoSorbents, Bluejay Diagnostics, Meihua Intl Medical Techs, IMAC Hldgs, P3 Health Partners, and NeoGenomics witnessed declines in their share prices by 38.7%, 29.18%, 29.16%, 23.71%, 19.55%, and 18.49% respectively.

Portfolio Pulse from Benzinga Insights

December 28, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.